搜索





搜索





市场行情
/
股票
/
legn
/

Legend Biotech Corp

LEGN

添加自选

18.550USD

-0.500-2.62%

收盘 07-31 16:00（美东）报价延迟15分钟

3.59B总市值

亏损市盈率 TTM

Legend Biotech Corp

18.550

-0.500-2.62%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

LEGN 利润表

您可以在这里找到Legend Biotech Corp的年度或季度收入报告，以深入了解Legend Biotech Corp的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

营业总收入

56.42%305.10M

64.26%306.38M

69.99%272.33M

36.74%255.06M

107.52%195.05M

134.73%186.52M

66.86%160.21M

154.36%186.52M

158.67%93.99M

--79.46M

--96.01M

512.56%73.33M

-27.39%36.34M

-40.83%11.97M

265.74%50.04M

-55.05%18.03M

43.71%16.88M

74.42%20.23M

18.50%13.68M

80.94%40.11M

-33.54%11.75M

15.00%11.60M

14.85%11.55M

--22.17M

--17.67M

--10.09M

--10.05M

营业收入

56.49%305.10M

64.51%306.49M

70.28%272.31M

38.54%255.06M

115.04%194.96M

134.56%186.30M

66.60%159.92M

151.27%184.10M

149.90%90.66M

--79.42M

--95.99M

512.04%73.27M

-27.44%36.28M

-40.83%11.97M

265.44%50.00M

-55.05%18.03M

43.71%16.88M

74.42%20.23M

18.50%13.68M

80.94%40.11M

-33.54%11.75M

15.00%11.60M

14.85%11.55M

--22.17M

--17.67M

--10.09M

--10.05M

主营业务成本

146.55%175.90M

67.01%123.46M

107.87%115.31M

94.23%97.99M

30.33%71.34M

127.80%73.92M

27.58%55.47M

54.42%50.45M

53.71%54.74M

--32.45M

--43.48M

92.88%32.67M

--35.61M

--16.94M

--0.00

----

营业费用

44.44%354.90M

24.68%326.01M

36.96%315.78M

21.20%276.94M

15.98%245.70M

30.40%261.48M

22.29%230.56M

28.62%228.49M

31.86%211.85M

--200.52M

--188.54M

35.34%177.65M

39.09%160.66M

19.88%131.26M

23.89%115.51M

56.05%156.48M

31.24%103.65M

61.89%109.49M

60.80%93.23M

23.01%100.27M

63.29%78.98M

72.19%67.63M

130.53%57.98M

--81.52M

--48.37M

--39.28M

--25.15M

研发费用

-15.92%85.70M

-2.97%101.33M

18.45%113.15M

-12.72%98.30M

0.95%101.92M

-1.18%104.43M

-0.35%95.52M

17.57%112.63M

18.94%100.96M

--105.68M

--95.86M

39.18%95.79M

4.10%84.89M

-17.53%68.83M

14.74%81.55M

29.24%86.50M

13.60%72.31M

55.80%83.46M

48.06%71.07M

1.27%66.93M

51.86%63.66M

64.11%53.57M

125.48%48.00M

--66.10M

--41.92M

--32.64M

--21.29M

折旧摊销及损耗

200.06%15.60M

76.10%11.97M

11.60%6.11M

9.03%5.85M

-9.14%5.20M

27.00%6.80M

5.82%5.47M

--5.37M

--5.72M

--5.35M

--5.17M

----

248.45%2.02M

----

--580.00K

其他营业费用

--3.20M

--30.00K

----

营业利润

1.67%-49.80M

73.81%-19.63M

38.24%-43.45M

47.87%-21.88M

57.03%-50.65M

38.08%-74.96M

23.96%-70.36M

59.77%-41.97M

5.20%-117.86M

---121.05M

---92.52M

12.55%-104.31M

-89.90%-124.33M

-33.65%-119.28M

17.70%-65.47M

-130.11%-138.45M

-29.06%-86.77M

-59.29%-89.25M

-71.32%-79.55M

-1.37%-60.17M

-119.04%-67.23M

-91.96%-56.03M

-207.56%-46.43M

---59.35M

---30.70M

---29.19M

---15.10M

净非营业利息收入（费用）

利息收入

-39.45%7.30M

-41.78%7.95M

-41.91%9.66M

-38.81%10.43M

-13.08%12.06M

-21.08%13.65M

--16.63M

--17.05M

--13.87M

--17.30M

----

-51.57%849.00K

----

--1.75M

利息费用

8.67%5.50M

6.39%5.48M

2.40%5.64M

-4.78%5.22M

-7.56%5.06M

-11.48%5.15M

-3.03%5.50M

5.77%5.48M

7.08%5.47M

--5.82M

--5.68M

215.58%5.18M

389.75%5.11M

3059.62%1.64M

2647.37%1.04M

1405.00%602.00K

131.11%208.00K

-40.91%52.00K

-99.05%38.00K

-52.38%40.00K

9.76%90.00K

363.16%88.00K

10402.63%3.99M

--84.00K

--82.00K

--19.00K

--38.00K

出售证券收益

89.31%-5.90M

---3.40M

---128.00K

---109.99M

---55.19M

----

-41.86%568.00K

----

--977.00K

特殊收入（费用）

----

100.00%0.00

-316.04%-970.00K

-3328.68%-4.42M

---201.00K

99.77%-248.00K

-97.76%449.00K

---129.00K

--0.00

-60.47%-105.75M

-42.69%20.00M

-4018.75%-65.90M

--34.90M

--31.20M

---35.80M

98.00%-1.60M

----

--0.00

---79.98M

0.00%3.00K

--0.00

--3.00K

其他非经营性收入（费用）

16.96%800.00K

-99.13%969.00K

100.78%482.00K

-85.30%1.86M

-98.61%684.00K

400.15%111.39M

-272.13%-61.46M

-22.72%12.68M

2042.09%49.23M

---37.11M

--35.70M

362.89%16.41M

-392.23%-2.54M

-823.52%-6.24M

60.75%-515.00K

-182.22%-1.47M

-830.74%-1.97M

-155.05%-676.00K

-223.08%-1.31M

122.24%1.79M

-90.95%270.00K

65.28%1.23M

3907.14%1.07M

--805.00K

--2.98M

--743.00K

---28.00K

税前利润

46.43%-53.10M

-148.38%-19.60M

67.68%-39.07M

-594.48%-124.80M

-65.80%-99.13M

127.59%40.51M

-93.43%-120.89M

90.96%-17.97M

46.60%-59.79M

---146.81M

---62.49M

-2.99%-198.84M

-248.54%-111.97M

-110.82%-193.07M

60.29%-32.13M

-87.14%-109.32M

-86.05%-124.75M

32.10%-91.58M

-68.76%-80.90M

0.36%-58.42M

-141.27%-67.05M

-373.81%-134.88M

-285.66%-47.94M

---58.63M

---27.79M

---28.47M

---12.43M

所得税

-32.81%1.20M

-21.16%11.22M

-86.11%616.00K

157.52%582.00K

35620.00%1.79M

813.49%14.23M

1639.93%4.43M

-22.07%226.00K

-96.09%5.00K

---1.99M

---288.00K

84.71%290.00K

-21.47%128.00K

15600.00%157.00K

--163.00K

90.41%-3.62M

100.00%0.00

--1.00K

100.00%0.00

-44.59%-37.70M

-10260.00%-508.00K

-100.00%0.00

---3.71M

---26.07M

--5.00K

--336.00K

--0.00

除税后利润

46.19%-54.30M

-217.24%-30.82M

68.33%-39.69M

-589.05%-125.38M

-68.78%-100.92M

118.15%26.28M

-101.46%-125.32M

90.86%-18.20M

46.66%-59.79M

---144.82M

---62.21M

-3.05%-199.13M

-247.18%-112.10M

-110.98%-193.23M

60.09%-32.29M

-410.10%-105.71M

-87.47%-124.75M

32.10%-91.58M

-82.91%-80.90M

36.36%-20.72M

-139.40%-66.55M

-368.29%-134.88M

-255.82%-44.23M

---32.56M

---27.80M

---28.80M

---12.43M

持续经营利润

46.19%-54.30M

-217.24%-30.82M

68.33%-39.69M

-589.05%-125.38M

-68.78%-100.92M

118.15%26.28M

-101.46%-125.32M

90.86%-18.20M

46.66%-59.79M

---144.82M

---62.21M

-3.05%-199.13M

-247.18%-112.10M

-110.98%-193.23M

60.09%-32.29M

-410.10%-105.71M

-87.47%-124.75M

32.10%-91.58M

-82.91%-80.90M

36.36%-20.72M

-139.40%-66.55M

-368.29%-134.88M

-255.82%-44.23M

---32.56M

---27.80M

---28.80M

---12.43M

归属于母公司的净利润

46.19%-54.30M

-217.24%-30.82M

68.33%-39.69M

-589.05%-125.38M

-68.78%-100.92M

118.15%26.28M

-101.46%-125.32M

90.86%-18.20M

46.66%-59.79M

---144.82M

---62.21M

-3.05%-199.13M

-247.18%-112.10M

-110.98%-193.23M

60.09%-32.29M

-410.10%-105.71M

-87.47%-124.75M

32.10%-91.58M

-82.91%-80.90M

36.36%-20.72M

-139.40%-66.55M

-368.29%-134.88M

-255.82%-44.23M

---32.56M

---27.80M

---28.80M

---12.43M

归属于普通股东的净利润

46.19%-54.30M

-217.24%-30.82M

68.33%-39.69M

-589.05%-125.38M

-68.78%-100.92M

118.15%26.28M

-101.46%-125.32M

90.86%-18.20M

46.66%-59.79M

---144.82M

---62.21M

-3.05%-199.13M

-247.18%-112.10M

-110.98%-193.23M

60.09%-32.29M

-410.10%-105.71M

-87.47%-124.75M

32.10%-91.58M

-82.91%-80.90M

36.36%-20.72M

-139.40%-66.55M

-368.29%-134.88M

-255.82%-44.23M

---32.56M

---27.80M

---28.80M

---12.43M

基本每股收益

46.58%-0.15

-216.45%-0.08

68.56%-0.11

-583.38%-0.34

-67.16%-0.27

117.99%0.07

-99.54%-0.34

91.23%-0.05

51.57%-0.16

---0.40

---0.17

8.92%-0.57

-224.27%-0.34

-88.67%-0.62

65.57%-0.10

-360.71%-0.36

-70.92%-0.43

36.59%-0.33

-77.70%-0.30

51.96%-0.08

-134.30%-0.25

-368.29%-0.52

-255.80%-0.17

---0.16

---0.11

---0.05

稀释每股收益

46.58%-0.15

-216.45%-0.08

68.56%-0.11

-583.38%-0.34

-67.16%-0.27

117.99%0.07

-99.54%-0.34

91.23%-0.05

51.57%-0.16

---0.40

---0.17

8.92%-0.57

-224.27%-0.34

-88.67%-0.62

65.57%-0.10

-360.71%-0.36

-70.92%-0.43

36.59%-0.33

-77.70%-0.30

51.96%-0.08

-134.30%-0.25

-368.29%-0.52

-255.80%-0.17

---0.16

---0.11

---0.05

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Legend Biotech Corp 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 LEGN 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Legend Biotech Corp 财年末的营收是多少？



Legend Biotech Corp 2025 财年营收为 1.03B，高于上一财年的627.24M。

Legend Biotech Corp 最近一个季度的营收是多少？



Legend Biotech Corp 最近一个季度的营收为 305.10M，同比增长 56.42%。

Legend Biotech Corp 全年的净利润是多少？



Legend Biotech Corp 2025 财年净利润为 -296.80M。

Legend Biotech Corp 上一季度的净利润是多少？



Legend Biotech Corp 最近一个季度的净利润为 -54.30M。

Legend Biotech Corp 年度营业利润是多少？



Legend Biotech Corp 2025 财年的营业利润为 -136.50M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。